Synthetic Biologics, Inc. is a clinical phase company. The company develops therapies to protect intestinal microbiomas while targeting specific pathogenic diseases. The main candidates for Phase II companies are SYN-010, which aims…
Synthetic Biologics, Inc. is a clinical phase company. The company develops therapies to protect intestinal microbiomas while targeting specific pathogenic diseases. The main candidates for Phase II companies are SYN-010, which aims…